[Clinical therapeutic experiences with a standardized combination of A and B glycoside fractions of Digitalis purpurea].
D000368:Aged; D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D001281:Atrial Fibrillation / Q000150:complications; D001919:Bradycardia / Q000150:complications; D005117:Cardiac Complexes, Premature / Q000139:chemically induced; D006332:Cardiomegaly / Q000150:complications; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000150:complications; D004071:Digitalis Glycosides / Q000009:adverse effects / Q000627:therapeutic use*; D004074:Digitoxin / Q000009:adverse effects / Q000627:therapeutic use*; D006322:Heart Aneurysm / Q000150:complications; D006333:Heart Failure / Q000188:drug therapy* / Q000209:etiology; D006349:Heart Valve Diseases / Q000150:complications; D006801:Humans; D006973:Hypertension / Q000150:complications; D007674:Kidney Diseases / Q000150:complications; D008171:Lung Diseases / Q000150:complications; D008875:Middle Aged; D013122:Spinal Diseases / Q000150:complications; D013607:Tablets; D013610:Tachycardia / Q000150:complications
D004071:Digitalis Glycosides; D013607:Tablets; D004074:Digitoxin
Klinischer Erfahrungsbericht über die Therapie mit einer standardisierten Kombination der A- und B-Glykosidfraktionen der Digitalis purpurea.